|
|
|
Volumn 24, Issue 1 SUPPL. 3, 1997, Pages
|
|
Response to estramustine phosphate and paclitaxel in patients with advanced breast cancer: A phase I study
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTRAMUSTINE PHOSPHATE;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
ESTRAMUSTINE;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG POTENTIATION;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT PLANNING;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
FATIGUE;
MIDDLE AGED;
NAUSEA;
OVARY TUMOR;
TREATMENT OUTCOME;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
ESTRAMUSTINE;
FATIGUE;
FEMALE;
HUMANS;
MIDDLE AGED;
NAUSEA;
OVARIAN NEOPLASMS;
PACLITAXEL;
TREATMENT OUTCOME;
VOMITING;
|
|
EID: 0031055159
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (8)
|
